SHADE Newsletter 3rd April 2025

Welcome to the thirty fifth edition of the SHADE newsletter! 

SHADE is a research hub with a mission to explore issues at the intersection of digital technologies/AI, health and the environment. It is guided by a fundamental question: How should the balance between AI/digital enabled health and planetary health be struck in different areas of the world, and what should be the guiding principles?

The SHADE newsletter comes out every two weeks, taking an in depth look at selected topics, as well as highlighting new resources, events and opportunities in the SHADE space.

In this newsletter we highlight the benefits of, and the challenges around, accessing, sharing, regulating and managing data. We also zoom in on low- and middle-income countries (LMICs), looking at their successes in identifying disease outbreaks, their use of digital health tools, their changing funding landscape and their vulnerabilty to human pathogenic bacteria. We conclude with a packed selection of resources, events and opportunities. We hope you enjoy it!

Please tell us what you like, what you don’t like and what you think is missing at [email protected]  

Data

  • Check out this free Atlas of Longitudinal Data Sets. As Louise Arsenault, who led the Wellcome funded project, explains in this LinkedIn post, longitudinal data sets ‘can help us understand how people’s health and behaviours change across time, and how the brain, body and environment interact’. With a vision to facilitate research by maximising the use of existing data, the Atlas focusses on mental health but also contains datasets relating to physical health conditions and socioeconomic factors.

  • Meanwhile, ‘unprecedented access to longitudinal academic records of a Chilean student cohort’ meant this study is ‘one of the first to robustly analyze the long-term effects of environmental pollution on student performance in a non-U.S., non-high-income setting’. The latest epiosde of the One World One Health podcast talks to one of the study’s authors.

  • Nature reports on a big pharma consortium planning to use their own data to improve AlphaFold - but with no plans to make the resulting model available outside the consortium. Opinion is divided as to whether this initiative could eventually lead pharma companies to sharing more of their internal data.

  • The European Health Data Space regulation came into effect in March. It is the first common EU space dedicated to a specific sector and fosters interoperability and data re-use, which can benefit research and minimise environmental impacts - for example those associated with data duplication. How this interoperability and re-use will be implemented is still unclear as this blog from IQVIA highlights.

  • Understanding and Mitigating Webpage Data Bloat: Causes and Preventive Measures: This paper from Hotcarbon.org resulted in the Green Page Analyzer tool which can analyze the amount of data on any public webpage. It also provides recommendations for reducing the amount of data without removing content.

LMICs

  • African scientists set genomics ‘world speed record’ in confirming Ebola outbreak in Uganda, contributing to a collaborative model that ‘could go a long way to improving the identification, tracking, monitoring and combatting of disease outbreaks in Africa’ reports Nature Africa.

  • This study in the International Journal of Medical Informatics ‘significantly advances our understanding of digital health tools (DHTs) by providing actual data on their use in climate change-vulnerable countries’. Taking the perspective of local healthcare practitioners, the study ‘highlights the necessity of context-specific capacity-building initiatives by evaluating the professional preparedness to use DHTs and the sufficiency of training’.

  • With the known link between climate change and infectious disease, and the backdrop of the changing funding landscape for infectious disease research and control, this editorial in the International Journal of Infectious Diseases highlights the impact of recent cuts in funding from high-income countries and considers the implications for resource-limited countries. It calls for LMICs to prioritise self-sustainability in their health programs. Meanwhile this paper in Vaccine undertakes an analysis of the funding landscape for human bacterial vaccines in low-and middle-income countries. It finds that ‘most funding was received by organisations in North America and Europe, with Asia, Africa, and Central/South America collectively receiving less than 20% of the total funding’. It also highlights that ‘data gaps remain for critical bacterial pathogens on WHO's AMR priority pathogen list’.

  • This paper from Science Advances constructed and analyzed a global atlas of potential human pathogenic bacteria (HPB) using over a million samples worldwide. The study found that ‘human activities and climate change could profoundly affect the distribution, richness, and dispersal of HPB in the environment, highlighting the necessity and urgency of reducing greenhouse gas emissions and assisting LMICs in improving medical conditions’.

Resources, Events and Opportunities

And finally, this comment piece in Nature outlines six ways to tackle the ‘carbon catch-22: governments are hesitant to impose regulations without clear price signals from markets, while markets struggle to deliver price clarity without regulatory guidance’.

We hope you have enjoyed this newsletter. If it has been forwarded to you, and you would like to receive future editions, you can subscribe here